# A Clinical Trial of Chidamide in the Management of Refractory ITP

> **NCT03838354** · PHASE1,PHASE2 · COMPLETED · sponsor: **Shandong University** · enrollment: 61 (actual)

## Conditions studied

- Thrombocytopenia

## Interventions

- **DRUG:** Chidamide
- **DRUG:** Chidamide

## Key facts

- **NCT ID:** NCT03838354
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2025-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03838354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03838354, "A Clinical Trial of Chidamide in the Management of Refractory ITP". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03838354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*